Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Change in Receivables (2019 - 2026)

Catalyst Pharmaceuticals filings provide 9 years of Change in Receivables readings, the most recent being $4.4 million for Q1 2026.

  • On a quarterly basis, Change in Receivables fell 24.74% to $4.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $59.6 million, a 453.0% increase, with the full-year FY2025 number at $61.0 million, up 409.96% from a year prior.
  • Change in Receivables hit $4.4 million in Q1 2026 for Catalyst Pharmaceuticals, down from $20.1 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $40.5 million in Q3 2025 to a low of -$5.4 million in Q2 2025.
  • Median Change in Receivables over the past 5 years was $5.3 million (2023), compared with a mean of $7.3 million.
  • The widest YoY moves for Change in Receivables: up 18466.67% in 2022, down 239.65% in 2022.
  • Catalyst Pharmaceuticals' Change in Receivables stood at $1.1 million in 2022, then surged by 395.92% to $5.5 million in 2023, then skyrocketed by 31.93% to $7.2 million in 2024, then surged by 178.34% to $20.1 million in 2025, then tumbled by 78.29% to $4.4 million in 2026.
  • The last three reported values for Change in Receivables were $4.4 million (Q1 2026), $20.1 million (Q4 2025), and $40.5 million (Q3 2025) per Business Quant data.